AstraZeneca has seen major momentum in oncology in recent years. It got a big showcase at Europe's top cancer conference.
After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types.
Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes ...
Five years after being diagnosed with multiple sclerosis, actor Christina Applegate revealed this week that she had been ...
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early ...
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, ...
A multiple sclerosis treatment from Novartis cut by a third the rates of relapses that people with the condition have ...
I felt Christina Applegate’s disappointment as if it were my own — because not long ago, it was,” writes Lindsay Karp.
As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna ...
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure ...
A new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.
Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results